1. RNA-Targeted Therapeutics in Cardiovascular Risk Reduction: From Gene Silencing to Precision Cardiology
Karim A, Binte Imran S, Yousuf Ym, Asad D, Hassan Z, Rahman H, Et Al.
Advances in cardiovascular prevention and treatment have substantially improved patient outcomes. However, residual cardiovascular risk remains a major clinical challenge. Traditional lipid-lowering and antihypertensive therapies, although effective, remain limited by suboptimal adherence, adverse effects, and…
- RNA therapeutics
- antisense oligonucleotides
- cardiovascular disease
- precision cardiology
- small interfering RNA
